ATE363269T1 - Verbesserte dosierform mit kontrollierter freisetzung mit stehantrieb - Google Patents

Verbesserte dosierform mit kontrollierter freisetzung mit stehantrieb

Info

Publication number
ATE363269T1
ATE363269T1 AT04788968T AT04788968T ATE363269T1 AT E363269 T1 ATE363269 T1 AT E363269T1 AT 04788968 T AT04788968 T AT 04788968T AT 04788968 T AT04788968 T AT 04788968T AT E363269 T1 ATE363269 T1 AT E363269T1
Authority
AT
Austria
Prior art keywords
dosage form
reservoir
engine
controlled release
present
Prior art date
Application number
AT04788968T
Other languages
English (en)
Inventor
Si-Hong Yum
Crystal Pollock-Dove
Liang-Chang Dong
Patrick S L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE363269T1 publication Critical patent/ATE363269T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Coating With Molten Metal (AREA)
  • Powder Metallurgy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT04788968T 2003-09-26 2004-09-24 Verbesserte dosierform mit kontrollierter freisetzung mit stehantrieb ATE363269T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50656303P 2003-09-26 2003-09-26

Publications (1)

Publication Number Publication Date
ATE363269T1 true ATE363269T1 (de) 2007-06-15

Family

ID=34393171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04788968T ATE363269T1 (de) 2003-09-26 2004-09-24 Verbesserte dosierform mit kontrollierter freisetzung mit stehantrieb

Country Status (9)

Country Link
US (1) US20050186273A1 (de)
EP (1) EP1667652B1 (de)
JP (1) JP2007506753A (de)
KR (1) KR20060076318A (de)
AT (1) ATE363269T1 (de)
CA (1) CA2540044A1 (de)
DE (1) DE602004006763T2 (de)
ES (1) ES2287778T3 (de)
WO (1) WO2005030164A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682521B2 (en) 2000-03-23 2004-01-27 Dennis N. Petrakis Temperature activated systems
US7445616B2 (en) * 2001-03-23 2008-11-04 Petrakis Dennis N Temperature responsive systems
US7607402B2 (en) 2001-03-23 2009-10-27 Petrakis Dennis N Temperature responsive systems
US7655001B2 (en) 2001-03-23 2010-02-02 Petrakis Dennis N Temperature responsive systems
US7476224B2 (en) * 2003-03-17 2009-01-13 Petrakis Dennis N Temperature responsive systems
KR20060070575A (ko) * 2003-09-26 2006-06-23 알자 코포레이션 활성성분 제제의 방출제어용 제형
WO2007041079A2 (en) * 2005-09-30 2007-04-12 Alza Corporation Banded controlled release nanoparticle active agent formulation dosage forms and methods
US20080067108A1 (en) * 2006-09-14 2008-03-20 Halliburton Energy Services, Inc. Methods and compositions for thermally treating a conduit used for hydrocarbon production or transmission to help remove paraffin wax buildup
CN103434229B (zh) * 2013-08-22 2015-09-16 华南理工大学 一种多层定向控释抗菌膜及其制备方法与应用
US9011964B1 (en) * 2014-12-06 2015-04-21 Albert S. Zeng Nano-encapsulated, controlled drug manufacturing process
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
EP3487485A2 (de) 2016-07-19 2019-05-29 Johnson & Johnson Consumer Inc. Tabletten mit unterbrochenen beschichteten regionen
US12484904B2 (en) * 2021-06-10 2025-12-02 Cilag Gmbh International Systems, devices and methods of repairing tendons and ligaments

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4478658A (en) * 1982-12-20 1984-10-23 Warner-Lambert Company Method for sealing non-enteric capsules
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
US5245357A (en) * 1988-09-07 1993-09-14 Seiko Epson Corporation Page printer
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
WO1999018159A1 (en) * 1997-10-06 1999-04-15 Alza Corporation Injection-moldable composition and article of manufacture comprising same
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
ATE292453T1 (de) * 1999-12-09 2005-04-15 Alza Corp Antivirale arznei
DE10036173A1 (de) * 2000-07-25 2002-02-07 Basf Ag Verfahren zum Entsäuern eines Fluidstroms und Waschflüssigkeit zur Verwendung in einem derartigen Verfahren
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
HUP0402661A3 (en) * 2001-12-19 2008-04-28 Alza Corp Formulation and dosage form for the controlled delivery of therapeutic agents
NZ533060A (en) * 2001-12-19 2006-03-31 Alza Corp Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules

Also Published As

Publication number Publication date
EP1667652A2 (de) 2006-06-14
ES2287778T3 (es) 2007-12-16
WO2005030164A3 (en) 2006-03-30
CA2540044A1 (en) 2005-04-07
US20050186273A1 (en) 2005-08-25
HK1093430A1 (en) 2007-03-02
EP1667652B1 (de) 2007-05-30
KR20060076318A (ko) 2006-07-04
DE602004006763D1 (de) 2007-07-12
WO2005030164A2 (en) 2005-04-07
DE602004006763T2 (de) 2008-02-07
JP2007506753A (ja) 2007-03-22

Similar Documents

Publication Publication Date Title
ATE363269T1 (de) Verbesserte dosierform mit kontrollierter freisetzung mit stehantrieb
MX2007000564A (es) Metodo para utilizar efectivamente medicamentos referentes a la prevencion de efectos secundarios.
SE0301886D0 (sv) New use V
WO2006006172A3 (en) Use of anti-amyloid agents for treating and typing pathogen infections
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
TW200600112A (en) Oral care method
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
DE60111500D1 (de) Neue wirkstoffkombination, enthaltend einen inhibitor der epinephrinaufnahme sowie einen antimuskarinen wirkstoff
BRPI0509127A (pt) agentes terapêuticos para distúrbios do ouvido interno contendo um antagonista de il-6 como ingredientes ativo
BRPI0409945A (pt) forma de dosagem resistente à alteração
DK3210909T3 (da) Hydrofilt kateter i en pakning
ATE280594T1 (de) Wundauflage
WO2004047673A3 (en) Treatment of liver disease with active vitamin d compounds
WO2003090712A3 (en) Compositions for treating hyperemia
BR0317924A (pt) Formas de dosagem não aquosas de composto de prostaglandina e
HK1046631A1 (zh) 含有酮替芬的眼药组合物
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
WO2001041754A3 (en) Inhibitors of collagen-induced platelet aggregation
WO2002007731A3 (en) Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma
HK1046367A1 (zh) 治疗过敏和炎症症状
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
PL362944A1 (en) Mixture of active compounds, application of the mixture, microbicide compound, method of preservation of technical materials and technical materials
WO2006009718A3 (en) Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2006121717A3 (en) Skin care compositions containing idebenone
WO2002055022A3 (en) Active metabolite of antifungal compound

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties